Donepezil increases the concentration of acetylcholine through reversible inhibition of its hydrolysis by acetylcholinesterase. There is no evidence that donepezil alters the course of the underlying ...
Donepezil (Donecept 10) is a cholinesterase inhibitor, prescribed for dementia of Alzheimer's disease. It works by increasing the amount of acetylcholine in the brain, which helps in improving mental ...
WASHINGTON, DC — Adding a potent antagonist of the 5-HT6 serotonin receptor (RVT-101, Axovant Sciences Inc) to standard dementia care with donepezil (Aricept, Eisai Inc and Pfizer Inc) improves ...
Background Cholinesterase inhibitors can delay the progression of Alzheimer's disease (AD). Several clinical trials of the drug in moderate to severe AD have consistently reported clinically positive ...
Credit: Shutterstock. Adlarity is a once-weekly transdermal formulation of donepezil that is designed to be worn for 7 days with consistent adhesion. The Food and Drug Administration (FDA) has ...
Woodcliff Lake, NJ, and New York, July 23, 2010 - Eisai Inc. and Pfizer Inc [NYSE: PFE] announced today that the U.S. Food and Drug Administration (FDA) approved a new once-daily, higher-dose Aricept ...
Experts have urged GPs to keep prescribing the drug donepezil to patients in the later stages of Alzheimer’s disease because they say it can help them to continue living at home for longer. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback